September 29, 2021 Amring Pharmaceuticals Inc, a niche generic and brand pharmaceutical company, announced a license agreement with Pierre Fabre Farma de Mexico, S.A. de C.V. for LYSTEDA (tranexamic acid). Read more
August 5, 2021 Amring Pharmaceuticals Inc., a niche brand and generic pharmaceuticals company, announced today that it has received FDA approval for generic Isoproterenol Hydrochloride USP and has immediately begun commercialization activity. Read...
June 24, 2019 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it has launched two valued drugs into its generic portfolio and to the U.S. Market: Succinylcholine Chloride Injection, a generic...
January 4, 2019 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it launched a generic oncology drug, Arsenic Trioxide Injection in November 2018 and expects to launch four (4) additional...
July 17, 2018 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical company, today announced the release of its latest product, Biolon OVD (ophthalmic viscosurgical device). Amring is excited to offer this new, cost-effective device and position itself in the...
Recent Comments